Huifeng Bio-Pharmaceutical Technology reported it expects 2009 revenues to be between $13 million and $14 million, about 30% better than last year. Net income is forecast to be as much as $3 million. The big news is that Huifeng predicts 2010’s revenues will be in a range between $20 million and $25 million, an increase of 50% or more. More details...

Stock Symbol: (OTCBB: HFGB)